Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-09-27Clinical Trial Update: Activity of Inspiratory Muscles With the Use of Positive Pressure in Patients With Chronic Obstructive Pulmonary Disease [NA]
This clinical trial examines inspiratory muscle activity with the use of positive pressure in patients with chronic obstructive pulmonary di…
-
CLINICAL_TRIALS trial_result · 2011-09-23Clinical Trial Update: Tiotropium In Exercise [Phase 4]
This Clinical Trial Update reports the completion and posted results of a Phase 4 study evaluating tiotropium use during exercise in patient…
-
CLINICAL_TRIALS trial_result · 2011-09-23Clinical Trial Update: PulseHaler Drug Deposition Study in Chronic Obstructive Pulmonary Disease Patients [NA]
A completed clinical trial update on PulseHaler deposition in chronic obstructive pulmonary disease patients, sponsored by Respinova LTD. Th…
-
CLINICAL_TRIALS trial_result · 2011-09-16Clinical Trial Update: Cough Responses to Tussive Agents in Health and Disease
This completed clinical trial assessed cough responses to tussive agents in health and disease, including chronic obstructive pulmonary dise…
-
CLINICAL_TRIALS research · 2011-09-09Clinical Trial Update: Effects of Exercise Training on Systemic Inflammation an Muscle Repair According to the Obstructive Chronic Pulmonary Disease (COPD) Phenotype [Phase 4]
A Phase 4 clinical trial is evaluating how exercise training affects systemic inflammation and muscle repair across COPD phenotypes, with cu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2011-09-07Clinical Trial Update: Pulmonary Function, Chronic Obstructive Pulmonary Disease (COPD) Prevalence, and Systemic Inflammation in Chronic Heart Failure With or Without COPD [NA]
Completed clinical trial evaluating pulmonary function, prevalence of chronic obstructive pulmonary disease, and systemic inflammation in pa…
-
CLINICAL_TRIALS trial_result · 2011-09-01Clinical Trial Update: Continuous Positive Airway Pressure Versus Noninvasive Ventilation in Patients With Overlap Syndrome [Phase 3]
Phase 3 trial comparing continuous positive airway pressure versus noninvasive ventilation in overlap syndrome (COPD and obstructive sleep a…
-
CLINICAL_TRIALS trial_result · 2011-08-30Clinical Trial Update: An Exploratory Study, to Assess the Effect of Repeat-dose Inhaled Indacaterol Maleate (300 μg) on Dynamic and Static Lung Hyperinflation, Subjective Breathlessness and Health Status in Patients With Chronic Obstructive Pulmonary Disease(COPD) [Phase 2]
Phase 2 exploratory clinical trial evaluating repeat-dose inhaled indacaterol maleate (300 μg) on lung hyperinflation, breathlessness, and h…
-
CLINICAL_TRIALS trial_result · 2011-08-19Clinical Trial Update: Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease [Phase 3]
Phase 3 trial evaluating the efficacy and safety of adding indacaterol to tiotropium versus tiotropium alone in chronic obstructive pulmonar…
-
CLINICAL_TRIALS trial_result · 2011-08-19Clinical Trial Update: 12-week Efficacy of Indacaterol [Phase 3]
Novartis completed a Phase 3 trial assessing the 12-week efficacy of indacaterol in chronic obstructive pulmonary disease, with results post…
-
CLINICAL_TRIALS trial_result · 2011-08-19Clinical Trial Update: Comparison of Efficacy of Indacaterol Versus Placebo Over 12 Weeks [Phase 3]
A Phase 3 trial compares indacaterol to placebo over 12 weeks in chronic obstructive pulmonary disease, with results posted.
-
CLINICAL_TRIALS trial_result · 2011-08-19Clinical Trial Update: Efficacy and Safety of Different Doses of Indacaterol in Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
A Phase 3 trial evaluated the efficacy and safety of different doses of indacaterol in chronic obstructive pulmonary disease, with results p…
-
CLINICAL_TRIALS trial_result · 2011-08-19Clinical Trial Update: Safety/Tolerability Study With AZD1236 in Chronic Obstructive Pulmonary Disease (COPD) Patients [Phase 2]
A Phase 2 safety and tolerability trial of AZD1236 in chronic obstructive pulmonary disease has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2011-08-19Clinical Trial Update: Comparison of the Effects of Indacaterol and Tiotropium on Inspiratory Capacity [Phase 3]
A Phase 3 trial comparing indacaterol to tiotropium on inspiratory capacity in COPD patients, with results posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-08-19Clinical Trial Update: A Study to Compare the Lung Effect of Indacaterol and Tiotropium in Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
A Phase 3 trial comparing the lung effects of indacaterol versus tiotropium in chronic obstructive pulmonary disease completed, with results…
-
FDA approval · 2011-08-18FDA Approved: DULERA — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for DULERA (mometasone furoate/formoterol fumarate dihydrate) submitted by Organon LLC.
-
CLINICAL_TRIALS trial_result · 2011-08-18Clinical Trial Update: Safety, Tolerability and Efficacy of Indacaterol in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
Phase 3 trial assessing safety, tolerability and efficacy of indacaterol in moderate-to-severe COPD; results completed and posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-08-18Clinical Trial Update: Efficacy, Safety, and Tolerability of Once Daily Indacaterol in Chronic Obstructive Pulmonary Disease (COPD) Using Formoterol Twice Daily as Active Control [Phase 3]
Phase 3 trial evaluating once-daily indacaterol versus twice-daily formoterol as an active control in COPD, reporting efficacy, safety, and …
-
FDA approval · 2011-08-18FDA Approved: BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for Budesonide and Formoterol Fumarate Dihydrate (Symbicort) from AstraZeneca.
-
CLINICAL_TRIALS trial_result · 2011-08-18Clinical Trial Update: A Crossover Study to Determine the 24 Hour Lung Function Profile of Indacaterol in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
This entry reports the completion and posting of results for a Phase 3 crossover study assessing the 24-hour lung function profile of indaca…
-
CLINICAL_TRIALS trial_result · 2011-08-18Clinical Trial Update: 26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 2, Phase 3]
A 26-week Phase 2/3 study evaluated the efficacy, safety and tolerability of indacaterol in patients with chronic obstructive pulmonary dise…
-
CLINICAL_TRIALS trial_result · 2011-08-18Clinical Trial Update: Efficacy and Safety of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
This is a Phase 3 clinical trial update assessing the efficacy and safety of indacaterol in chronic obstructive pulmonary disease. Results w…
-
CLINICAL_TRIALS trial_result · 2011-08-18Clinical Trial Update: Safety and Efficacy of Indacaterol Once Daily Versus Salmeterol Twice Daily in Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
Phase 3 trial comparing indacaterol once daily with salmeterol twice daily in COPD completed with results posted.
-
CLINICAL_TRIALS trial_result · 2011-08-18Clinical Trial Update: AZD2115 Single Ascending Dose Study [Phase 1]
A Phase 1 single ascending dose trial of AZD2115 in chronic obstructive pulmonary disease has completed.
-
CLINICAL_TRIALS trial_result · 2011-08-18Clinical Trial Update: Efficacy and Safety of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) Using Salmeterol as Active Control [Phase 3]
Phase 3 clinical trial comparing indacaterol to salmeterol in COPD patients reports efficacy and safety data. The study is completed and res…